Intraoperative Tumor Margin Identification With ICG Dye Imaging
NCT04752137
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Benign Neoplasm
Malignant Neoplasm
Interventions
DRUG:
Indocyanine green
DEVICE:
SPY-PHI
Sponsor
Massachusetts General Hospital